Get started
Author

Nicolas Silva Lazaretti

Observed names: Lazaretti,Nicolas S., Lazaretti,Nicolas Silva, N Lazaretti, N. Lazaretti, N. S. Lazaretti, Nicolas Lazaretti, Nicolas S Lazaretti, Nicolas Silva Lazaretti, Nícolas Silva Lazaretti
Observed institutions: The University of Texas MD Anderson Cancer Center, AC Camargo Hospital, Hospital Moinhos de Vento, Hospital de Clínicas de Porto Alegre, Hospital São Vicente de Paulo, Hospital Araújo Jorge, Hospital São Vicente, Instituto Nacional de Câncer - INCA, Latin American Cooperative Oncology Group (LACOG), Universidade Federal de Goiás
OpenAlex ID: A5046722360
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
2023 · Shannon N. Westin, Kathleen Moore, et al. · Journal of Clinical Oncology · 416
PDF
Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
2018 · Michele Maio, Karl Lewis, et al. · The Lancet Oncology · 218
Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma
2025 · Michael Wang, David Salek, et al. · Journal of Clinical Oncology · 84
The impact of sociodemographic factors and health insurance coverage in the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115)
2020 · Daniela Dornelles Rosa, José Bines, et al. · Breast Cancer Research and Treatment · 80
Advanced Stage at Diagnosis and Worse Clinicopathologic Features in Young Women with Breast Cancer in Brazil: A Subanalysis of the AMAZONA III Study (GBECAM 0115)
2019 · Maria Alice Franzoi, Daniela D. Rosa, et al. · Journal of Global Oncology · 63
PDF
A randomised phase II study of chemoradiotherapy with or without nimotuzumab in locally advanced oesophageal cancer: NICE trial
2017 · Gilberto de Castro Junior, José Getúlio Segalla, et al. · European Journal of Cancer · 57
Marantic endocarditis and adenocarcinoma of unknown primary site.
2011 · Luis Alberto Schlittler, Viviane Weiller Dallagasperina, et al. · PubMed · 11
Sociodemographic and clinicopathologic features of elderly breast cancer patients in Brazil: A sub-analysis of AMAZONA III study (GBCAM 0115).
2021 · Carla Pavei, Daniela Dornelles Rosa, et al. · Journal of Clinical Oncology · 5
Germline Genetic Testing in Breast Cancer: Utilization and Disparities in a Middle-Income Country
2025 · Alessandra Borba Anton de Souza, Carlos Barrios, et al. · JCO Global Oncology · 4
PDF
Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate
2023 · Luis Fein, Nicolas Lazaretti, et al. · Clinical Drug Investigation · 4
PDF
A randomized, open-label phase II study of efatutazone in combination with FOLFIRI as second-line therapy for metastatic colorectal cancer (mCRC).
2014 · John Marshall, Dale Edward Shuster, et al. · Journal of Clinical Oncology · 4
True adrenal cyst mimicking renal cancer in a young woman: a case report
2009 · Luis Alberto Schlittler, Viviane Weiller Dallagasperina, et al. · Cases Journal · 4
PDF
Effect of crossover from placebo to darolutamide on overall survival in men with non-metastatic prostate cancer: sensitivity analyses from the randomised phase 3 ARAMIS study
2023 · Neal D. Shore, Karim Fizazi, et al. · European Journal of Cancer · 2
PDF
A clinical-pathological correlation in the diagnosis of breast sarcoma
2017 · Laura dos Santos Cesa, Bárbara Cristina Filippini, et al. · Revista Brasileira de Mastologia · 2
PDF
Tumor de células gigantes de fémur distal com metástases pulmonares
2010 · Nicolas S Lazaretti, Viviane Weiller Dallagasperina, et al. · Revista Portuguesa de Pneumologia · 2
PDF
Determinants of delayed postoperative radiation therapy in breast cancer patients undergoing neoadjuvant chemotherapy: A subanalysis of the AMAZONA III prospective cohort
2026 · Júlio César Prestes, Gustavo Viani, et al. · Cancer Treatment and Research Communications · 1
Analysis of the effect of crossover from placebo (PBO) to darolutamide (DARO) on overall survival (OS) benefit in the ARAMIS Trial.
2021 · Neal D. Shore, Karim Fizazi, et al. · Journal of Clinical Oncology · 1
Abstract P1-08-29: Current status of clinical and pathological characteristics of breast cancer patients in Brazil: Results of the AMAZONA III study (GBECAM 0115)
2019 · D Rosa, C Barrios, et al. · Cancer Research · 1
Abstract P1-08-27: Advanced stage at diagnosis and worse clinicopathologic features in young woman with breast cancer. A sub-analysis of Brazilian population through the AMAZONA III study (GBECAM 0115)
2019 · MA Franzoi, D Rosa, et al. · Cancer Research · 1
Molecular Marker Analyses of Egfr and Kras from the Randomized Phase Ii Study of Nimotuzumab in Locally Advanced Esophageal Cancer (Nice Trial)
2014 · G. De Castro, N. Skare, et al. · Annals of Oncology · 1
Carcinoma de Pequenas Células do Esófago: Apresentação de dois Casos
2011 · Luís Alberto Schlittler, Nicolas Lazaretti, et al. · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · 1
PDF
Mortality rate with irinotecan/cisplatin plus concomitant radiation therapy in patients with locally advanced esophageal squamous cell carcinoma
2009 · G. Geib, M. W. Machado, et al. · Journal of Clinical Oncology · 1
Survival After Multimodal Treatment for Breast Cancer in Brazil: The Predominant Role of Clinical Stage and Treatment Response
2026 · Júlio Cesar Prestes, Andre Guimares Gouveia, et al. · Clinical Breast Cancer
Abstract P3-01-07: Breast Cancer Survival According to Health Insurance Coverage in Brazil: Results from the Prospective AMAZONA III Study (GBECAM 0115)
2025 · Daniela Dornelles Rosa, José Bines, et al. · Clinical Cancer Research
Determinants of Delayed Postoperative Radiation Therapy in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy in Brazil
2025 · Júlio César Prestes, Gustavo Arruda Viani, et al. · SSRN Electronic Journal
Works count: 36
Citation count: 963
H-index: 7
I10-index: 7
Year
Topic
Type